HEADER    INHIBITOR                               16-JUL-03   1OK0              
TITLE     CRYSTAL STRUCTURE OF TENDAMISTAT                                      
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ALPHA-AMYLASE INHIBITOR HOE-467A;                          
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: TENDAMISTAT                                                 
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: STREPTOMYCES TENDAE;                            
SOURCE   3 ORGANISM_TAXID: 1932;                                                
SOURCE   4 STRAIN: 4158;                                                        
SOURCE   5 ATCC: 31210                                                          
KEYWDS    INHIBITOR, ALPHA AMYLASE INHIBITOR                                    
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    V.KOENIG,L.VERTESY,T.R.SCHNEIDER                                      
REVDAT   4   24-JUL-19 1OK0    1       REMARK                                   
REVDAT   3   08-MAY-19 1OK0    1       REMARK                                   
REVDAT   2   24-FEB-09 1OK0    1       VERSN                                    
REVDAT   1   15-JAN-04 1OK0    0                                                
JRNL        AUTH   V.KOENIG,L.VERTESY,T.R.SCHNEIDER                             
JRNL        TITL   CRYSTAL STRUCTURE OF THE ALPHA-AMYLASE INHIBITOR TENDAMISTAT 
JRNL        TITL 2 AT 0.93 A                                                    
JRNL        REF    ACTA CRYSTALLOGR.,SECT.D      V.  59  1737 2003              
JRNL        REFN                   ISSN 0907-4449                               
JRNL        PMID   14501112                                                     
JRNL        DOI    10.1107/S0907444903015828                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    0.93 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 0.93                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 10.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 93.5                           
REMARK   3   CROSS-VALIDATION METHOD           : THROUGHOUT                     
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.103                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.103                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.130                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 5                      
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 2054                   
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.093                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.092                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.120                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : NULL                   
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 558                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 13                                            
REMARK   3   SOLVENT ATOMS      : 159                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : NULL                    
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : NULL                    
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 15                      
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 7433                    
REMARK   3   NUMBER OF RESTRAINTS                     : 10184                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.015                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.033                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL                    
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.341                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.082                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.097                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.026                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.005                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.033                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.087                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER                                    
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1OK0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JUL-03.                  
REMARK 100 THE DEPOSITION ID IS D_1290013036.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 15-FEB-99                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 1.50                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : EMBL/DESY, HAMBURG                 
REMARK 200  BEAMLINE                       : X11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.911                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MAR SCANNER 345 MM PLATE           
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 261064                             
REMARK 200  RESOLUTION RANGE HIGH      (A) : 0.930                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 40.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 93.5                               
REMARK 200  DATA REDUNDANCY                : 6.900                              
REMARK 200  R MERGE                    (I) : 0.05400                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 20.3000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.93                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 0.95                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 79.9                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.50                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.32600                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 4.300                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: NULL                                                  
REMARK 200 STARTING MODEL: PDB ENTRY 1HOE                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 38.58                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 20MG OF LYOPHILIZED PROTEIN WERE         
REMARK 280  DISSOLVED IN 1ML OF DOUBLE-DISTILLED WATER. USING THE HANGING       
REMARK 280  DROP METHOD WITH DROPS OF 2MUL PROTEIN SOLUTION (20 MG/ML) AND      
REMARK 280  2MUL RESERVOIR SOLUTION (0.1-0.5 M NACL ADJUSTED TO PH 1.3 WITH     
REMARK 280  HYDROCHLORIC ACID), YIELDED TUFT-SHAPED AGGLOMERATES OF             
REMARK 280  ESSENTIALLY ONE-DIMENSIONAL CRYSTALS. STREAK SEEDING {EM VIA} A     
REMARK 280  CAT WHISKER AFTER TOUCHING THESE AGGLOMERATES GAVE SINGLE           
REMARK 280  CRYSTALS WITH DIMENSIONS UP TO 0.1 X 0.01 X 0.01MM^3, PH 1.50,      
REMARK 280  VAPOR DIFFUSION, HANGING DROP                                       
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       12.84000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       30.47500            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       20.39000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       30.47500            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       12.84000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       20.39000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 MAMMALIAN ALPHA-AMYLASES, BUT DOES NOT INHIBIT PLANT AND             
REMARK 400  MICROBIAL ALPHA-AMYLASES. KNOWN TO FORM A 1:1 COMPLEX WITH          
REMARK 400  ALPHA-AMYLASE                                                       
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ASP A   1   CB  -  CG  -  OD1 ANGL. DEV. =   9.1 DEGREES          
REMARK 500    TYR A  15   CB  -  CG  -  CD2 ANGL. DEV. =   5.0 DEGREES          
REMARK 500    TYR A  15   CB  -  CG  -  CD1 ANGL. DEV. =  -4.2 DEGREES          
REMARK 500    ASP A  58   CB  -  CG  -  OD2 ANGL. DEV. =   5.5 DEGREES          
REMARK 500    ARG A  68   NE  -  CZ  -  NH1 ANGL. DEV. =   3.1 DEGREES          
REMARK 500    ARG A  72   NE  -  CZ  -  NH1 ANGL. DEV. =   3.6 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A2043        DISTANCE =  6.21 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 701                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 601                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BVN   RELATED DB: PDB                                   
REMARK 900 PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THEPROTEINACEOUS        
REMARK 900 INHIBITOR TENDAMISTAT                                                
REMARK 900 RELATED ID: 1HOE   RELATED DB: PDB                                   
REMARK 900 ALPHA-AMYLASE INHIBITOR HOE-467A                                     
REMARK 900 RELATED ID: 2AIT   RELATED DB: PDB                                   
REMARK 900 TENDAMISTAT                                                          
REMARK 900 RELATED ID: 3AIT   RELATED DB: PDB                                   
REMARK 900 TENDAMISTAT (ENERGY MINIMIZED MODEL USING "AMBER" 3.0) (NMR)         
REMARK 900 RELATED ID: 4AIT   RELATED DB: PDB                                   
REMARK 900 TENDAMISTAT (ENERGY MINIMIZED MODEL USING "FANTOM") (NMR)            
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 THE SEQUENCE CONFLICT IS DESCRIBED IN THE REFERENCES THAT            
REMARK 999 ACCOMPANY THE SWS ENTRY P01092                                       
DBREF  1OK0 A    1    74  UNP    P01092   IAA_STRTE       31    104             
SEQADV 1OK0 GLU A   29  UNP  P01092    GLN    59 SEE REMARK 999                 
SEQRES   1 A   74  ASP THR THR VAL SER GLU PRO ALA PRO SER CYS VAL THR          
SEQRES   2 A   74  LEU TYR GLN SER TRP ARG TYR SER GLN ALA ASP ASN GLY          
SEQRES   3 A   74  CYS ALA GLU THR VAL THR VAL LYS VAL VAL TYR GLU ASP          
SEQRES   4 A   74  ASP THR GLU GLY LEU CYS TYR ALA VAL ALA PRO GLY GLN          
SEQRES   5 A   74  ILE THR THR VAL GLY ASP GLY TYR ILE GLY SER HIS GLY          
SEQRES   6 A   74  HIS ALA ARG TYR LEU ALA ARG CYS LEU                          
HET    GOL  A 501       6                                                       
HET    GOL  A 601       6                                                       
HET     CL  A 701       2                                                       
HETNAM     GOL GLYCEROL                                                         
HETNAM      CL CHLORIDE ION                                                     
HETSYN     GOL GLYCERIN; PROPANE-1,2,3-TRIOL                                    
FORMUL   2  GOL    2(C3 H8 O3)                                                  
FORMUL   4   CL    CL 1-                                                        
FORMUL   5  HOH   *159(H2 O)                                                    
SHEET    1  AA 3 VAL A  12  GLN A  16  0                                        
SHEET    2  AA 3 TYR A  20  ASN A  25 -1  O  GLN A  22   N  TYR A  15           
SHEET    3  AA 3 ILE A  53  ASP A  58 -1  O  THR A  54   N  ALA A  23           
SHEET    1  AB 3 TYR A  46  VAL A  48  0                                        
SHEET    2  AB 3 VAL A  31  TYR A  37 -1  O  VAL A  31   N  VAL A  48           
SHEET    3  AB 3 ALA A  67  ARG A  72 -1  N  ARG A  68   O  VAL A  36           
SSBOND   1 CYS A   11    CYS A   27                          1555   1555  2.05  
SSBOND   2 CYS A   45    CYS A   73                          1555   1555  2.06  
SITE     1 AC1  7 THR A   2  THR A   3  ARG A  19  CYS A  45                    
SITE     2 AC1  7 GOL A 601  HOH A2156  HOH A2159                               
SITE     1 AC2  7 GLN A  52  ASP A  58  GLY A  62  SER A  63                    
SITE     2 AC2  7 HOH A2118  HOH A2131  HOH A2152                               
SITE     1 AC3 13 SER A  10  CYS A  11  TYR A  20  CYS A  45                    
SITE     2 AC3 13  CL A 701  HOH A2030  HOH A2102  HOH A2154                    
SITE     3 AC3 13 HOH A2155  HOH A2156  HOH A2157  HOH A2158                    
SITE     4 AC3 13 HOH A2159                                                     
CRYST1   25.680   40.780   60.950  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.038941  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.024522  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.016407        0.00000                         
ATOM      3  CA AASP A   1      21.434  30.592  20.244  0.59  9.20           C  
ANISOU    3  CA AASP A   1     1405   1080   1009    -48    334    -99       C  
ATOM      4  CA BASP A   1      21.543  30.614  20.186  0.41  9.38           C  
ANISOU    4  CA BASP A   1     1441   1140    983      5     36   -241       C  
ATOM     18  CA  THR A   2      22.594  28.830  17.046  1.00  6.69           C  
ANISOU   18  CA  THR A   2      919    953    671   -104    -61    -26       C  
ATOM     26  CA ATHR A   3      20.809  26.042  15.179  0.76  6.31           C  
ANISOU   26  CA ATHR A   3      869    956    571   -245   -180    172       C  
ATOM     27  CA BTHR A   3      20.864  26.052  15.168  0.24  6.68           C  
ANISOU   27  CA BTHR A   3      970   1045    523   -201   -122    108       C  
ATOM     39  CA  VAL A   4      23.639  24.858  12.924  1.00  7.58           C  
ANISOU   39  CA  VAL A   4      834   1232    816   -373     72     -9       C  
ATOM     46  CA  SER A   5      23.261  21.286  14.119  1.00  7.12           C  
ANISOU   46  CA  SER A   5      739   1197    768   -166    -30    221       C  
ATOM     52  CA  GLU A   6      20.381  19.452  12.516  1.00  5.72           C  
ANISOU   52  CA  GLU A   6      765    911    499    -30      8    276       C  
ATOM     64  CA  PRO A   7      17.473  18.802  14.965  1.00  5.66           C  
ANISOU   64  CA  PRO A   7      665    954    531    -12     -4    196       C  
ATOM     74  CA  ALA A   8      16.623  15.251  15.805  1.00  6.48           C  
ANISOU   74  CA  ALA A   8      916    949    596   -251   -103    235       C  
ATOM     79  CA  PRO A   9      13.306  13.976  14.534  1.00 11.75           C  
ANISOU   79  CA  PRO A   9     1476   2222    766   -989   -376    516       C  
ATOM     88  CA  SER A  10      10.374  15.274  16.516  1.00 14.02           C  
ANISOU   88  CA  SER A  10     1498   1310   2519    -54   -401    916       C  
ATOM     94  CA  CYS A  11       9.553  11.742  17.726  1.00  7.20           C  
ANISOU   94  CA  CYS A  11      724   1115    896    -92   -176    216       C  
ATOM    100  CA  VAL A  12      12.614  12.115  19.982  1.00  5.65           C  
ANISOU  100  CA  VAL A  12      652    926    570   -125     21    -32       C  
ATOM    108  CA ATHR A  13      11.775  14.313  22.943  0.62  6.69           C  
ANISOU  108  CA ATHR A  13      799   1050    695    210   -165   -190       C  
ATOM    109  CA BTHR A  13      11.623  14.150  23.071  0.38  4.53           C  
ANISOU  109  CA BTHR A  13      431    777    513    226    -90     63       C  
ATOM    121  CA  LEU A  14      14.081  16.187  25.215  1.00  5.01           C  
ANISOU  121  CA  LEU A  14      666    688    548     65      8     53       C  
ATOM    129  CA  TYR A  15      13.656  16.396  28.982  1.00  5.81           C  
ANISOU  129  CA  TYR A  15      634   1038    536    -24     82    -30       C  
ATOM    149  CA  GLN A  16      15.994  18.342  31.292  1.00  5.12           C  
ANISOU  149  CA  GLN A  16      730    784    432    132    -65     18       C  
ATOM    158  CA  SER A  17      15.765  18.464  35.081  1.00  5.13           C  
ANISOU  158  CA  SER A  17      668    855    427     40      0   -104       C  
ATOM    164  CA  TRP A  18      18.220  20.220  37.358  1.00  4.84           C  
ANISOU  164  CA  TRP A  18      760    662    418     42     31    -86       C  
ATOM    178  CA  ARG A  19      20.370  17.104  37.189  1.00  4.19           C  
ANISOU  178  CA  ARG A  19      591    641    360      6    -23    -70       C  
ATOM    189  CA  TYR A  20      19.743  15.229  33.893  1.00  5.42           C  
ANISOU  189  CA  TYR A  20      915    723    423    216   -139   -133       C  
ATOM    201  CA  SER A  21      19.237  15.860  30.167  1.00  4.24           C  
ANISOU  201  CA  SER A  21      539    709    363     47    -11    -94       C  
ATOM    207  CA  GLN A  22      17.402  12.881  28.716  1.00  4.31           C  
ANISOU  207  CA  GLN A  22      547    635    456    -17    -97     53       C  
ATOM    216  CA  ALA A  23      16.395  11.843  25.212  1.00  4.30           C  
ANISOU  216  CA  ALA A  23      446    788    401    -24    -57     53       C  
ATOM    221  CA  ASP A  24      13.276   9.760  24.822  1.00  4.26           C  
ANISOU  221  CA  ASP A  24      534    604    483    -16    -43     19       C  
ATOM    233  CA  ASN A  25      13.040   7.957  21.486  1.00  5.07           C  
ANISOU  233  CA  ASN A  25      729    771    428   -118    -80    -20       C  
ATOM    241  CA  GLY A  26       9.438   7.465  20.354  1.00  5.53           C  
ANISOU  241  CA  GLY A  26      688    920    492   -161    -59    -56       C  
ATOM    245  CA  CYS A  27      10.513   6.878  16.750  1.00  5.78           C  
ANISOU  245  CA  CYS A  27      784    981    432   -226      6    -80       C  
ATOM    251  CA  ALA A  28      10.455   3.506  14.958  1.00  7.17           C  
ANISOU  251  CA  ALA A  28      946    984    793   -314    -49   -157       C  
ATOM    257  CA AGLU A  29      14.221   3.493  14.477  0.50  9.20           C  
ANISOU  257  CA AGLU A  29      901   1660    936   -216     41   -656       C  
ATOM    258  CA BGLU A  29      14.219   3.214  14.600  0.50  7.60           C  
ANISOU  258  CA BGLU A  29      884   1255    750   -258    177   -305       C  
ATOM    275  CA ATHR A  30      17.280   3.981  16.677  0.50  7.96           C  
ANISOU  275  CA ATHR A  30      855   1389    780   -210     31   -391       C  
ATOM    276  CA BTHR A  30      17.319   4.078  16.666  0.50  7.18           C  
ANISOU  276  CA BTHR A  30      749   1310    670   -177    231   -339       C  
ATOM    289  CA AVAL A  31      18.510   7.503  16.670  0.50  6.82           C  
ANISOU  289  CA AVAL A  31      724   1277    591    -96      5   -192       C  
ATOM    290  CA BVAL A  31      18.317   7.772  16.515  0.50  6.29           C  
ANISOU  290  CA BVAL A  31      802   1159    430   -148     73    -11       C  
ATOM    302  CA  THR A  32      21.834   9.116  17.414  1.00  5.73           C  
ANISOU  302  CA  THR A  32      734    957    488     33     48    -32       C  
ATOM    309  CA  VAL A  33      21.449  12.355  19.304  1.00  4.89           C  
ANISOU  309  CA  VAL A  33      571    793    495     13     31     49       C  
ATOM    316  CA  LYS A  34      23.397  15.003  21.162  1.00  4.87           C  
ANISOU  316  CA  LYS A  34      608    868    376     64    -18     66       C  
ATOM    326  CA AVAL A  35      22.307  17.860  23.392  0.61  5.12           C  
ANISOU  326  CA AVAL A  35      702    855    389    143    -28    127       C  
ATOM    327  CA BVAL A  35      22.071  17.789  23.305  0.39  5.55           C  
ANISOU  327  CA BVAL A  35      864    828    417    195    132    166       C  
ATOM    339  CA  VAL A  36      22.646  21.408  22.178  1.00  5.64           C  
ANISOU  339  CA  VAL A  36      755    811    577    115    -48     82       C  
ATOM    346  CA  TYR A  37      23.087  23.667  25.213  1.00  5.78           C  
ANISOU  346  CA  TYR A  37      912    703    583   -116    -38    119       C  
ATOM    358  CA  GLU A  38      22.261  27.358  25.542  1.00  8.38           C  
ANISOU  358  CA  GLU A  38     1144    711   1329     10    -59    167       C  
ATOM    367  CA  ASP A  39      25.972  28.208  25.334  1.00  8.81           C  
ANISOU  367  CA  ASP A  39     1237    812   1297   -225   -147     46       C  
ATOM    375  CA  ASP A  40      26.075  26.620  21.829  1.00  9.80           C  
ANISOU  375  CA  ASP A  40     1498   1280    945     36    156    386       C  
ATOM    383  CA  THR A  41      28.230  23.754  23.061  1.00  7.61           C  
ANISOU  383  CA  THR A  41      948   1000    945   -121    141    186       C  
ATOM    390  CA  GLU A  42      27.050  20.223  22.523  1.00  6.51           C  
ANISOU  390  CA  GLU A  42      702   1009    761    -20    -84     72       C  
ATOM    399  CA  GLY A  43      27.177  16.926  24.397  1.00  6.23           C  
ANISOU  399  CA  GLY A  43      740   1009    618     43    -49     89       C  
ATOM    403  CA  LEU A  44      28.377  13.553  23.209  1.00  5.53           C  
ANISOU  403  CA  LEU A  44      527   1056    517     64    108     70       C  
ATOM    411  CA  CYS A  45      26.477  11.441  20.669  1.00  5.61           C  
ANISOU  411  CA  CYS A  45      539   1149    441    188     50   -136       C  
ATOM    417  CA  TYR A  46      24.257   8.664  22.031  1.00  5.71           C  
ANISOU  417  CA  TYR A  46      633   1041    494    263     76     65       C  
ATOM    429  CA  ALA A  47      22.360   5.988  20.226  1.00  7.42           C  
ANISOU  429  CA  ALA A  47      694   1077   1049    103    252   -144       C  
ATOM    434  CA  VAL A  48      18.871   5.776  21.747  1.00  5.93           C  
ANISOU  434  CA  VAL A  48      667   1049    536    -10     70    -88       C  
ATOM    441  CA  ALA A  49      16.789   2.731  20.882  1.00  7.21           C  
ANISOU  441  CA  ALA A  49      803   1079    859    -78     39   -178       C  
ATOM    446  CA  PRO A  50      13.073   2.909  20.097  1.00  5.92           C  
ANISOU  446  CA  PRO A  50      666    989    595   -122     77    -62       C  
ATOM    453  CA  GLY A  51      11.192   3.053  23.379  1.00  5.81           C  
ANISOU  453  CA  GLY A  51      689    864    653   -121    161   -115       C  
ATOM    457  CA  GLN A  52      14.227   4.016  25.421  1.00  5.82           C  
ANISOU  457  CA  GLN A  52      723    891    598    -61    -38    101       C  
ATOM    467  CA AILE A  53      14.834   7.094  27.609  0.62  5.59           C  
ANISOU  467  CA AILE A  53      705    669    751   -206   -139    135       C  
ATOM    468  CA BILE A  53      14.761   6.954  27.684  0.38  6.75           C  
ANISOU  468  CA BILE A  53      965    855    744   -327   -226    228       C  
ATOM    483  CA ATHR A  54      18.604   7.734  27.904  0.62  3.99           C  
ANISOU  483  CA ATHR A  54      513    622    380    -49    -78     78       C  
ATOM    484  CA BTHR A  54      18.277   7.749  28.671  0.38  7.76           C  
ANISOU  484  CA BTHR A  54      912    997   1041   -215   -396    161       C  
ATOM    497  CA  THR A  55      20.585  10.315  29.877  1.00  4.95           C  
ANISOU  497  CA  THR A  55      566    713    602    -10   -150     86       C  
ATOM    504  CA  VAL A  56      22.533  12.274  27.266  1.00  4.41           C  
ANISOU  504  CA  VAL A  56      492    775    408     18     41    -89       C  
ATOM    511  CA  GLY A  57      23.799  15.333  29.111  1.00  4.44           C  
ANISOU  511  CA  GLY A  57      655    650    382     -5     67    -20       C  
ATOM    515  CA  ASP A  58      23.947  17.591  32.109  1.00  4.43           C  
ANISOU  515  CA  ASP A  58      623    630    430      4      3    -44       C  
ATOM    523  CA  GLY A  59      21.111  19.043  34.126  1.00  5.00           C  
ANISOU  523  CA  GLY A  59      676    674    552     29     62    -75       C  
ATOM    527  CA  TYR A  60      20.430  22.780  33.998  1.00  6.34           C  
ANISOU  527  CA  TYR A  60     1132    676    600     65   -157      7       C  
ATOM    539  CA  ILE A  61      22.473  23.356  37.193  1.00  7.00           C  
ANISOU  539  CA  ILE A  61     1302    720    637    -67   -112    -75       C  
ATOM    547  CA  GLY A  62      25.553  22.853  35.043  1.00  9.74           C  
ANISOU  547  CA  GLY A  62     1126   1563   1012   -368   -105    475       C  
ATOM    551  CA  SER A  63      27.779  25.408  33.431  1.00 10.45           C  
ANISOU  551  CA  SER A  63     1213   1791    966   -744   -157     84       C  
ATOM    557  CA  HIS A  64      26.300  24.814  29.989  1.00  7.24           C  
ANISOU  557  CA  HIS A  64     1201    842    709   -199   -114     55       C  
ATOM    567  CA  GLY A  65      22.866  25.756  31.268  1.00  8.58           C  
ANISOU  567  CA  GLY A  65     1204   1045   1011    -47   -114   -244       C  
ATOM    571  CA  HIS A  66      19.584  24.862  29.679  1.00  6.85           C  
ANISOU  571  CA  HIS A  66     1013    715    875     69    -41     68       C  
ATOM    581  CA  ALA A  67      19.350  22.229  26.982  1.00  6.35           C  
ANISOU  581  CA  ALA A  67      913    866    635    -23    -34     98       C  
ATOM    586  CA  ARG A  68      17.784  23.850  23.966  1.00  6.09           C  
ANISOU  586  CA  ARG A  68      797    899    617    183     59    135       C  
ATOM    597  CA  TYR A  69      17.161  20.900  21.648  1.00  5.54           C  
ANISOU  597  CA  TYR A  69      701    910    493    119    -22    147       C  
ATOM    609  CA  LEU A  70      18.448  17.504  20.632  1.00  5.02           C  
ANISOU  609  CA  LEU A  70      620    817    469     49     58    130       C  
ATOM    617  CA  ALA A  71      20.458  17.391  17.419  1.00  5.59           C  
ANISOU  617  CA  ALA A  71      790    936    397     42     42    180       C  
ATOM    622  CA  ARG A  72      20.959  14.310  15.325  1.00  6.37           C  
ANISOU  622  CA  ARG A  72      944    982    494    108    164     84       C  
ATOM    640  CA  CYS A  73      24.581  13.282  14.972  1.00  6.74           C  
ANISOU  640  CA  CYS A  73      842   1110    609    114    173     33       C  
ATOM    646  CA  LEU A  74      25.576  12.695  11.356  1.00  8.42           C  
ANISOU  646  CA  LEU A  74     1433   1174    590    281    260     89       C  
TER     654      LEU A  74                                                      
CONECT   98  249                                                                
CONECT  249   98                                                                
CONECT  415  644                                                                
CONECT  644  415                                                                
CONECT  655  656  657                                                           
CONECT  656  655                                                                
CONECT  657  655  658  659                                                      
CONECT  658  657                                                                
CONECT  659  657  660                                                           
CONECT  660  659                                                                
CONECT  661  662  663                                                           
CONECT  662  661                                                                
CONECT  663  661  664  665                                                      
CONECT  664  663                                                                
CONECT  665  663  666                                                           
CONECT  666  665                                                                
MASTER      256    0    3    0    6    0    8    6  730    1   16    6          
END                                                                             
